Skip to search formSkip to main contentSkip to account menu

A3309

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

elobixibat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
[The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs].
Inhibition of the apical sodium-dependent bile acid transporter (ASBT, also known as IBAT - ileal bile acid transporter, SLC10A2… 
2014
2014
Erratum: EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity…
2014
2014
Corrigendum: A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
2012
2012
Response to Drs Trivedi and Ward
To the Editor: We read with great interest the article by Chey et al. (1), which demonstrated promising results in the treatment… 
2011
2011
A3309, an Ileal Bile Acid Transport (IBAT /ASBT) Inhibitor, Significantly Improved Stool Frequency and Other Constipation-Related Complaints in Adults With Chronic Constipation: Data From an 8-Week…
2010
2010
S1302 Dose-Related Effects of Chenodeoxycholate on Gastrointestinal and Colonic Transit and Bowel Function in Female Patients With Constipation-Predominant Irritable Bowel Syndrome
2010
2010
S1299 The IBAT Inhibitor A3309 – A Promising Treatment Option for Patients With Chronic Idiopathic Constipation (Cic)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)